Skip to main content
OpenTrials
Completed

NCT Number: NCT00348023

Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension

Evaluate the IOP-lowering efficacy and quality of life in patients using bimatoprost 0.03% monotherapy versus dual therapy with travoprost 0.004% and timolol 0.5% for the treatment of glaucoma or ocular hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Dr. Noecker

Pittsburgh, Pennsylvania, 15213, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • · Male or female > 18 years of age
  • Diagnosis of primary open-angle glaucoma or ocular hypertension
  • Untreated IOP > 18 mm Hg in each eye at the baseline evaluation
  • Ability to provide informed consent and likely to complete all study visits

Exclusion criteria

  • · Known contraindication to bimatoprost, travoprost, timolol, or any component of any study medication
  • Uncontrolled systemic disease
  • Active ocular disease other than POAG or ocular hypertension
  • Required use of ocular medications other than the study medications during the study (intermittent use of OTC artificial tear products will be permitted)
  • History of intraocular surgery within the last 3 months
  • Patient must not have discontinued use of any medication included in this study in the past for reasons of efficacy or intolerance

Treatment and study plan

Bimatoprost 0.03%, Travoprost 0.004%, Timolol 0.5%

Drug

Sponsors and collaborators

Lead sponsor

Innovative Medical

Industry

Registry information

Official study title

Comparison of Bimatoprost 0.03% Monotherapy vs. Dual Therapy With Travoprost 0.004% and Timolol 0.5% in Patients With Glaucoma and Ocular Hypertension

Important dates

First posted
Jul 4, 2006
Registry last updated
Feb 9, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.